Clinical outcomes with the MammoSite radiation therapy system: results of a prospective trial.
William SmallTamer RefaatJonathan B StraussMahesh GopalakrishnanKevin P BethkeEllen B MendelsonJudith A WolfmanBorko D JovanovicKrystyna KielPublished in: Journal of radiation oncology (2015)
APBI delivered with the MammoSite RTS is a feasible, tolerable, and effective treatment modality. Multicenter, randomized, controlled clinical trials with a larger number of patients are required for verification.
Keyphrases
- clinical trial
- phase iii
- radiation therapy
- phase ii
- double blind
- end stage renal disease
- open label
- newly diagnosed
- ejection fraction
- chronic kidney disease
- study protocol
- placebo controlled
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- randomized controlled trial
- cross sectional
- patient reported outcomes
- radiation induced
- patient reported
- combination therapy